Alvarez et al., 2017 - Google Patents
Evaluation of four commercial virological assays for early infant HIV-1 diagnosis using dried blood specimensAlvarez et al., 2017
View HTML- Document ID
- 16168075648905417644
- Author
- Alvarez P
- Prieto L
- MartÃn L
- Obiang J
- Avedillo P
- Vargas A
- Rojo P
- Fernandez McPhee C
- Sanz Canalejas L
- Benito A
- Ramos J
- HolguÃn Ã
- Publication year
- Publication venue
- Pediatric Research
External Links
Snippet
Background: Early infant diagnosis (EID) of HIV-1 is necessary to reduce HIV-related mortality. As maternal antibodies transferred across the placenta may persist up to 18 mo, commercial virological assays (CVAs) are needed. This study compares four CVAs for EID …
- 241000713772 Human immunodeficiency virus 1 0 title abstract description 63
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—AIDS or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
- G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
- G01N2333/16—HIV-1, HIV-2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/493—Physical analysis of biological material of liquid biological material urine
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lilian et al. | Early diagnosis of in utero and intrapartum HIV infection in infants prior to 6 weeks of age | |
Kassanjee et al. | Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository | |
Sherman et al. | Polymerase chain reaction for diagnosis of human immunodeficiency virus infection in infancy in low resource settings | |
Jani et al. | Accurate early infant HIV diagnosis in primary health clinics using a point-of-care nucleic acid test | |
Slyker et al. | Clinical and virologic manifestations of primary Epstein-Barr virus (EBV) infection in Kenyan infants born to HIV-infected women | |
Payne et al. | Reactivity of routine HIV antibody tests in children who initiated antiretroviral therapy in early infancy as part of the Children with HIV Early Antiretroviral Therapy (CHER) trial: a retrospective analysis | |
Duong et al. | Poor performance of the determine HIV-1/2 Ag/Ab combo fourth-generation rapid test for detection of acute infections in a National Household Survey in Swaziland | |
Vidya et al. | Dried blood spots versus plasma for the quantitation of HIV-1 RNA using a real-Time PCR, m2000rt assay | |
Dinh et al. | Impact of timing of antiretroviral treatment and birth weight on mother-to-child human immunodeficiency virus transmission: findings from an 18-month prospective cohort of a nationally representative sample of mother–infant pairs during the transition from option A to option B+ in Zimbabwe | |
Sherman et al. | Affordable diagnosis of human immunodeficiency virus infection in infants by p24 antigen detection | |
Ibrahim et al. | Brief report: high sensitivity and specificity of the Cepheid Xpert HIV-1 qualitative point-of-care test among newborns in Botswana | |
Meggi et al. | Performance of point-of-care birth HIV testing in primary health care clinics: an observational cohort study | |
Alvarez et al. | HIV-1 variability and viral load technique could lead to false positive HIV-1 detection and to erroneous viral quantification in infected specimens | |
Pannus et al. | Sensitivity and specificity of dried blood spots for HIV-1 viral load quantification: A laboratory assessment of 3 commercial assays | |
Meggi et al. | Point-of-care p24 infant testing for HIV may increase patient identification despite low sensitivity | |
Viljoen et al. | Dried blood spot HIV-1 RNA quantification using open real-time systems in South Africa and Burkina Faso | |
Alvarez et al. | Evaluation of four commercial virological assays for early infant HIV-1 diagnosis using dried blood specimens | |
Sherman et al. | The performance of 5 rapid HIV tests using whole blood in infants and children: selecting a test to achieve the clinical objective | |
Rangsin et al. | The natural history of HIV-1 subtype E infection in young men in Thailand with up to 14 years of follow-up | |
Strehlau et al. | HIV diagnostic challenges in breast-fed infants of mothers on antiretroviral therapy | |
Ondiek et al. | Multicountry validation of SAMBA-A novel molecular point-of-care test for HIV-1 detection in resource-limited setting | |
Brun-Vézinet et al. | Update on the human immunodeficiency virus | |
Luo et al. | Use of an indeterminate range in HIV early infant diagnosis: A systematic review and meta-analysis | |
Madrid et al. | Congenital cytomegalovirus, parvovirus and enterovirus infection in Mozambican newborns at birth: a cross-sectional survey | |
Garcia-Prats et al. | False-negative post-18-month confirmatory HIV tests in HIV DNA PCR-positive children: a retrospective analysis |